0001209191-19-003397.txt : 20190111 0001209191-19-003397.hdr.sgml : 20190111 20190111151043 ACCESSION NUMBER: 0001209191-19-003397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190111 FILED AS OF DATE: 20190111 DATE AS OF CHANGE: 20190111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Castellanos Elaine CENTRAL INDEX KEY: 0001662520 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 19522229 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-11 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662520 Castellanos Elaine 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 0 1 0 0 Principal Accounting Officer Class A common stock 2019-01-11 4 C 0 2138 A 2138 D Employee Stock Option (right to buy) 8.11 2019-01-11 4 M 0 180 0.00 D 2019-02-03 Class B common stock 180 0 D Employee Stock Option (right to buy) 7.41 2019-01-11 4 M 0 1958 0.00 D 2020-01-15 Class B common stock 1958 0 D Class B common stock 2019-01-11 4 M 0 180 8.11 A Class A common stock 180 180 D Class B common stock 2019-01-11 4 M 0 1958 7.41 A Class A common stock 1958 2138 D Class B common stock 2019-01-11 4 C 0 2138 D Class A common stock 2138 0 D The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. The options vested in sixteen equal quarterly installments beginning on May 3, 2009. The options vested in sixteen equal quarterly installments beginning on April 15, 2010. /s/ Michael D. Wortley, attorney-in-fact 2019-01-11